Target intelligence / Profile preview

Axon terminal (or presynaptic terminal) (null)

Target
null
Molecular classification
Other (cellular/anatomical compartment, not a molecular target)
01

Overview

The nerve ending, also known as the axon terminal or presynaptic terminal, is the distal tip of a neuron where neurotransmitters are released to transmit signals to other neurons, muscle cells, or gland cells. It contains synaptic vesicles filled with neurotransmitters, mitochondria for energy supply, and various proteins involved in vesicle docking and fusion (e.g., SNARE complex, synapsin). Upon arrival of an action potential, voltage-gated sodium and calcium channels are activated, triggering calcium influx and subsequent fusion of synaptic vesicles with the plasma membrane, resulting in neurotransmitter exocytosis. The term "nerve ending" itself does not define a single molecule or receptor, but an anatomically and functionally specialized site for synaptic transmission, essential for nervous system communication. Therapeutically, drugs can target molecular processes at or within nerve endings, but the "nerve ending" is not a molecular target per se.

Other names
Nerve endingAxon terminalSynaptic boutonPresynaptic terminalTerminal bouton
02

Mechanism of action

Sodium channel blockade; Calcium channel modulation; SNARE protein inhibition; Modulation of neurotransmitter reuptake and degradation.

03

Biological functions

Neurotransmitter releaseSignal transductionSynaptic transmissionCommunication with muscles, glands, and other neuronsSensory reception
04

Disease associations

Neurodegenerative diseases (degeneration or dysfunction affects neurotransmission)Neuromuscular disordersPsychiatric disorders (altered synaptic transmission)Other (since dysfunction can contribute broadly to nervous system diseases)
05

Safety considerations

Neurotoxicity (certain drugs and toxins can irreversibly damage nerve endings)Synaptic failure in neurodegenerative conditionsTargeting nerve endings can lead to loss of sensory or motor function
06

Interacting drugs

Local anesthetics

2 more in the full profile.

Beyond the preview

Go deeper on Axon terminal (or presynaptic terminal) (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axon terminal (or presynaptic terminal) (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call